BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 629278)

  • 1. Circulating immune complexes in Hodgkin's disease.
    Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
    Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
    Brandeis WE; Tan C; Wang Y; Good RA; Day NK
    Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients.
    Velardi A; Spinozzi F; Rambotti P; Tabilio A; Losito A; Zampi I; Cernetti C; Martelli MF; Grignani F; Davis S
    J Clin Oncol; 1983 Feb; 1(2):117-25. PubMed ID: 6668495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
    J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes of Hodgkin's disease contain an antigen that is present in Hodgkin and Reed-Sternberg cells.
    Bepler G; Zhen QY; Havemann K
    J Cancer Res Clin Oncol; 1985; 110(1):56-64. PubMed ID: 2410427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes of patients with malignant lymphomas (author's transl)].
    Sodomann CP; Schmidt H; Havemann K
    Blut; 1979 Jun; 38(6):435-46. PubMed ID: 444682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
    Heier HE; Landaas TO; Marton PF
    Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes and symptoms in Hodgkin's disease.
    Amlot PL; Slaney JM; Williams BD
    Lancet; 1976 Feb; 1(7957):449-51. PubMed ID: 55719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.
    Long JC; Hall CL; Brown CA; Stamatos C; Weitzman SA; Carey K
    N Engl J Med; 1977 Aug; 297(6):295-9. PubMed ID: 559938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on circulating immune complexes. I: Circulating immune complexes in various types of glomerulonephritis and collagen disease: a comparative study employing conglutinin solid phase radioimmunoassay and raji cell radioimmunoassay.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):185-92. PubMed ID: 2739117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
    Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
    Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.